Refine by
Drug Response Suppliers & Manufacturers
30 companies found
based inPhiladelphia, PENNSYLVANIA (USA)
Our team came together at a health hackathon hosted by Independence Blue Cross and Thomas Jefferson University. Strados Labs founder, Nick Delmonico, is a patient who has spent time in the ER and the ICU due to asthma and respiratory illness like ...
Beyond Cough Count: RESP Cough Trial Solution (CTS) optimizes chronic cough trials to better capture lung sound biomarkers. RESP allows clinical endpoints for coughs to be captured and show positive results. A portion of these positive results ...
based inHeidelberg, GERMANY
Hummingbird is harnessing the predictive power of blood-borne miRNAs to provide insights into human health and disease. Analysis of miRNAs with Hummingbird’s platform holds the potential for early disease detection, disease-specific prognostics, ...
MiRNAs are small, highly conserved, non-coding RNAs playing crucial roles in the regulation of virtually all aspects of living ...
based inDurham, NORTH CAROLINA (USA)
GeneCentric Therapeutics is applying our proprietary rT(I)ME Explorer Platform to identify high resolution molecular subtypes and drug responder populations that enable the development of precision cancer drugs while improving patient outcomes. Our ...
GeneCentric has developed two gene expression profilers (LSP 210 and LSP 220) that define molecular subtypes of the two most common forms of non-small cell lung cancer (NSCLC), squamous cell carcinoma, and ...
based inBoston, MASSACHUSETTS (USA)
Accelerating Discovery in CNS, Cardiometabolic and Inflammatory Disease. We support our clients to achieve more in their target & biomarker programs. Our expertise, curated & disease enriched clinco-omic cohorts, tools and applications for insight ...
based inLondon, UNITED KINGDOM
We built an online platform through which we wanted to see a change in the way healthcare was delivered to our close family members. Now we want to change the status quo. We believe that the future of healthcare lies in precision medicine coupled ...
Now is the time to offer personalised services to your customers, helping them be more certain with COVID-19 PCR testing, optimise their treatment outcomes through genetic testing and have a tailored health, diet and wellness regimen through various ...
based inAtlanta, GEORGIA (US) (USA)
Axion BioSystems specializes in creating innovative bioelectronic and imaging systems designed to assist scientists and engineers in the life sciences field. Their technology allows for advanced monitoring and analysis of cellular activities in ...
based inShelton, CONNECTICUT (USA)
PerkinElmer is passionate about providing customers with an unmatched experience as they help solve critical issues, especially impacting the diagnostics, discovery and analytical solutions markets. See how together we are improving lives and the ...
based inMarseille Cedex 9, FRANCE
Veracyte, formerly HalioDx, is a global diagnostics company that improves patient care by answering important clinical questions to inform diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. Our ...
Immunogram, Veracyte’s advanced analytics platform, integrates multi-omic data sets and analyzes them into a single per patient view of key biomarker signatures, specific to their own Tumor Microenvironment. This analytics platform ...
based in, MASSACHUSETTS (USA)
MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The ...
Drug affinity responsive target stability is a label-free small molecule probe technique under chemical proteomics first proposed by Lomenick et al. in 2009, which makes it possible to track and identify target ...
based inFarmington, CONNECTICUT (USA)
Intus Biosciences’ world-leading cidentifies bacteria and delivers answers about the microbiome with unprecedented detail, accuracy and scale. Its patented, validated Titan-1™ platform combines high-throughput assay and analysis technology and is ...
Actionable Results for Industry and Patients. Our cutting-edge Titan-1 platform powers complete ‘sample to answer’ services for pharma, biotech and research partners and clients, delivering response prediction, biomarker identification, ...
based inBudapest, HUNGARY
Cytocast, an innovative TechBio startup located in Budapest, is at the forefront of data-driven medical technology.The company's primary focus is on integrating extensive multi-omics data with high-performance computing and advanced data science ...
Cytocast is at the forefront of medical technology with its innovative Cytocast Digital Twin Platform™, a pioneering solution in drug development and personalized medicine. At its core is the CYTOCAST DIGITAL TWIN Cell™, a highly ...
based inLittle Chesterford, UNITED KINGDOM
The microbiome represents a paradigm shift that affects every aspect of biomedicine: our gut bacteria control health, disease and drug response throughout the body, and can themselves be a novel type of medicine. The microbiome therefore has the ...
A fundamental challenge to any microbiome program is that human gut bacteria have been viewed as unculturable, and the microbiome of any individual could not be characterised with sufficient depth and precision to form a sound basis for translation. ...
based inIselin, NEW JERSEY (USA)
Excelra (formally Excelra Knowledge Solutions), established in 2016, is a dynamic informatics company focused on accelerating drug discovery and development through advanced data analytics and integrative informatics services. The organization ...
As the volume of biomedical data increases, so does the complexity of drug discovery and development programs. There’s a wealth of opportunity out there but capturing high-quality data and putting it to immediate productive use is often ...
based inBangalore, INDIA
Cellworks’ mission is to serve patients through advances in personalized medicine that significantly improve treatment success. We achieve better outcomes by predicting a successful match between patients and drug therapies – their Therapy Response ...
based inGosselies, BELGIUM
We are a genomic and theranostic company specializing in precision medicine for the treatment of patients with cancer and genetic diseases. OncoDNA is a company specializing in precision for the treatment of cancer and other genetic diseases. We are ...
OncoKDM® is an online platform that turns your NGS data into actionable clinical information. Moreover, OncoKDM® can integrate NGS results with IHC, MSI and TMB data. The resulting comprehensive and interactive report includes updated ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Docetaxel Trihydrate (RP-56976 Trihydrate) is an antineoplastic agent and inhibits microtubule depolymerization with an IC50 value of 0.2 μM[1]. Docetaxel Trihydrate is a semisynthetic analog of taxol and attenuates the effects ...
based inPune, INDIA
TOXINDIA is a Contractual Research Organization based in Pune. (Maharashtra - India), The Industrial, research & Academic Hub of 21st century India. With International standards & practices in place the lab has acquired the most preferred status ...
based inSeattle, WASHINGTON (USA)
SEngine Precision Medicine empowers patients and oncologists with more informed treatment options. SEngine's high-throughput technology simultaneously tests more than 200 cancer drugs against a patient's unique tumor organoid outside the body. The ...
based inCharlottesville, VIRGINIA (USA)
HemoShear Therapeutics is a clinical stage company developing novel treatments for patients with rare diseases. We are implementing a new vision for how advanced biological and computational models can accelerate the discovery of innovative ...
HST5040 is an investigational small molecule therapy being developed by HemoShear to reduce the levels of toxins associated with methylmalonic acidemia (MMA) and propionic acidemia (PA), rare genetic disorders caused by the de?ciency of certain ...
based inCraigavon, UNITED KINGDOM
The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally. Our innovative ...
We are uniquely placed to partner with clients throughout the entire process of CDx Development through our Clinical Trial Diagnostic ...
